📖

TREM2 Protein — Triggering Receptor Expressed on Myeloid Cells 2

wiki page Created: 2026-04-02 13:40:08 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-proteins-trem2-protein

Related Entities

Metadata

slug	proteins-trem2-protein
entity_type	protein
kg_node_id	TREM2PROTEIN

🌍 Provenance Graph 1 nodes, 0 edges

No provenance edges found

Linked Artifacts (412)

related🧪Cell-Type Specific TREM2 Upregulation in DAM Microglia90%

mentions🧫Microglial TREM2 Agonist In Vivo Efficacy80%

mentions🧫TREM2 Agonist Therapy for Parkinson's Disease — Experim80%

mentions🧫TREM2 Function in Alzheimer's Disease — From Risk Varia80%

mentions🧪TREM2 Conformational Stabilizers for Synaptic Discrimination80%

mentions🧪TREM2-mediated microglial tau clearance enhancement80%

mentions🔬Immune atlas neuroinflammation analysis in neurodegeneration75%

mentions🔬Neuroinflammation and microglial priming in early Alzheimer&75%

mentions🔬Neuroinflammation and microglial priming in early AD — Analy75%

mentions🔬Does SYK activation provide neuroprotection or exacerbate ne75%

mentions🔬What are the optimal timing windows for TREM2 agonism vs ant75%

mentions🔬Analysis question not specified75%

related🧫Microglial TREM2 Agonist In Vivo Efficacy72%

related🧫TREM2 Agonist Therapy for Parkinson's Disease — Experim72%

related🧫TREM2 Function in Alzheimer's Disease — From Risk Varia72%

mentions🧪TREM2 Conformational Stabilizers for Synaptic Discrimination70%

mentions🧪TREM2-mediated microglial tau clearance enhancement70%

mentions🧪Cell-Type Specific TREM2 Upregulation in DAM Microglia70%

mentions🧫s:** - GPR32 knockout in microglia should worsen neuroinflam70%

mentions🧫Proposed experiment from debate on Synaptic pruning by micro70%

mentions🧫s:** - Compare tau strain spreading in EXT1/EXT2 conditional70%

mentions🧫AD Amyloid-Resilient Phenotype Study — Why Some amyloid-Posi70%

mentions🧫Why Does Amyloid Removal Only Slow Decline 27%? — Mechanisti70%

mentions🧫Anti-Tau Antibody vs ASO/Gene Therapy — Comparative Efficacy70%

mentions🧫Anti-Tau Therapy Failure Mechanism in PSP — Why Clinical Tri70%

mentions🧫Experiment: Autoimmune Hypothesis Testing in AD70%

mentions🧫Blood Biomarker vs Tau PET for Treatment Monitoring70%

mentions🧫CBS vs PSP Phenotype Determinants — Single-Nucleus Multi-Omi70%

mentions🧫DLB Cognitive Fluctuation Mechanism Experiment70%

mentions🧫Genetic Risk Modifiers in DLB Phenotype70%

mentions🧫DLB Treatment Response Biomarkers — Predicting Cholinesteras70%

mentions🧫FTD Microglia Role: Protective vs Destructive Mechanism Stud70%

mentions🧫FTLD-Tau vs FTLD-TDP In Vivo Biomarker Differentiation70%

mentions🧫Microglial Aging and Immune Memory in Neurodegeneration — Tr70%

mentions🧫Microglial Contributions to Huntington's Disease Pathog70%

mentions🧫Mixed Pathology Effects on Parkinson's Disease Progress70%

mentions🧫Prodromal Parkinson's Disease Biomarker Development — E70%

mentions🧫Progranulin Replacement Therapy for FTD — Vector Development70%

mentions🧫PSP and CBS Biomarker Validation Study70%

mentions🧫Tau PET Pattern as Therapeutic Response Predictor in 4R-Tauo70%

mentions🧫Experiment Validation: In vitro ThT Assay70%

mentions🧫Tau ASO Therapy70%

mentions🧫TREM2 KO amyloid pathology study70%

mentions🧪Selective APOE4 Degradation via Proteolysis Targeting Chimer70%

mentions🧪APOE Isoform Conversion Therapy70%

mentions🧪APOE4 Allosteric Rescue via Small Molecule Chaperones70%

mentions🧪Engineered Apolipoprotein E4-Neutralizing Shuttle Peptides70%

related🧫ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De70%

related🧫Animal Model Comparison for Neurodegenerative Disease Therap70%

related🧫Endocannabinoid System Dysfunction Validation in Parkinson&#70%

related🧫Glymphatic-Circadian Axis Enhancement Therapy for Parkinson&70%

related🧫Gut Microbiome-Derived Metabolites in Alpha-Synuclein Propag70%

related🧫Neural Oscillation Dysfunction Validation in Parkinson'70%

related🧫Oligodendrocyte-Myelin Dysfunction Validation in Parkinson&#70%

related🧫Proteasome-Ubiquitin System Dysfunction Validation in Parkin70%

related🧫Protein Aggregation Kinetic Validation Results70%

related🧫Purinergic Signaling Dysfunction Validation in Parkinson70%

related🧫Regulated Necrosis Validation Study in Parkinson's Dise70%

related🧫Stress Granule Dysfunction Validation in Parkinson's Di70%

related🧫Experiment Validation: In vitro ThT Assay70%

related🧫Non-Motor Symptom Progression in Parkinson's Disease — 70%

related🧫ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De70%

related🧫Animal Model Comparison for Neurodegenerative Disease Therap70%

related🧫Endocannabinoid System Dysfunction Validation in Parkinson&#70%

related🧫Glymphatic-Circadian Axis Enhancement Therapy for Parkinson&70%

related🧫Gut Microbiome-Derived Metabolites in Alpha-Synuclein Propag70%

related🧫Neural Oscillation Dysfunction Validation in Parkinson'70%

related🧫Oligodendrocyte-Myelin Dysfunction Validation in Parkinson&#70%

related🧫Proteasome-Ubiquitin System Dysfunction Validation in Parkin70%

related🧫Protein Aggregation Kinetic Validation Results70%

related🧫Purinergic Signaling Dysfunction Validation in Parkinson70%

related🧫Regulated Necrosis Validation Study in Parkinson's Dise70%

related🧫Stress Granule Dysfunction Validation in Parkinson's Di70%

related🧫Experiment Validation: In vitro ThT Assay70%

related🧫Non-Motor Symptom Progression in Parkinson's Disease — 70%

related🧫Microglial TREM2 Agonist In Vivo Efficacy70%

related🧫TREM2 Agonist Therapy for Parkinson's Disease — Experim70%

related🧫TREM2 Function in Alzheimer's Disease — From Risk Varia70%

related🧪APOE-TREM2 Interaction Modulation70%

see_also📖al002-trem2-agonist-alzheimers70%

related🔬Immune atlas neuroinflammation analysis in neurodegeneration67%

related🔬Neuroinflammation and microglial priming in early Alzheimer&67%

related🔬Neuroinflammation and microglial priming in early AD — Analy67%

related🔬Does SYK activation provide neuroprotection or exacerbate ne67%

related🔬What are the optimal timing windows for TREM2 agonism vs ant67%

related🔬Analysis question not specified67%

mentions🧪Complement C1q Mimetic Decoy Therapy65%

mentions🧪Complement C1q Subtype Switching65%

mentions🧪Complement-Mediated Synaptic Pruning Dysregulation65%

related🧪TREM2 Conformational Stabilizers for Synaptic Discrimination63%

related🧪TREM2-mediated microglial tau clearance enhancement63%

related🧫s:** - GPR32 knockout in microglia should worsen neuroinflam63%

related🧫Proposed experiment from debate on Synaptic pruning by micro63%

related🧫s:** - Compare tau strain spreading in EXT1/EXT2 conditional63%

related🧫AD Amyloid-Resilient Phenotype Study — Why Some amyloid-Posi63%

related🧫Why Does Amyloid Removal Only Slow Decline 27%? — Mechanisti63%

related🧫Anti-Tau Antibody vs ASO/Gene Therapy — Comparative Efficacy63%

related🧫Anti-Tau Therapy Failure Mechanism in PSP — Why Clinical Tri63%

related🧫Experiment: Autoimmune Hypothesis Testing in AD63%

related🧫Blood Biomarker vs Tau PET for Treatment Monitoring63%

related🧫CBS vs PSP Phenotype Determinants — Single-Nucleus Multi-Omi63%

related🧫DLB Cognitive Fluctuation Mechanism Experiment63%

related🧫Genetic Risk Modifiers in DLB Phenotype63%

related🧫DLB Treatment Response Biomarkers — Predicting Cholinesteras63%

related🧫FTD Microglia Role: Protective vs Destructive Mechanism Stud63%

related🧫FTLD-Tau vs FTLD-TDP In Vivo Biomarker Differentiation63%

related🧫Microglial Aging and Immune Memory in Neurodegeneration — Tr63%

related🧫Microglial Contributions to Huntington's Disease Pathog63%

related🧫Mixed Pathology Effects on Parkinson's Disease Progress63%

related🧫Prodromal Parkinson's Disease Biomarker Development — E63%

related🧫Progranulin Replacement Therapy for FTD — Vector Development63%

related🧫PSP and CBS Biomarker Validation Study63%

related🧫Tau PET Pattern as Therapeutic Response Predictor in 4R-Tauo63%

related🧫Tau ASO Therapy63%

related🧫TREM2 KO amyloid pathology study63%

related🧪Selective APOE4 Degradation via Proteolysis Targeting Chimer63%

related🧪APOE Isoform Conversion Therapy63%

related🧪APOE4 Allosteric Rescue via Small Molecule Chaperones63%

related🧪Engineered Apolipoprotein E4-Neutralizing Shuttle Peptides63%

see_also📖Adipose-Derived Mesenchymal Stem Cell Therapy for Early Alzh60%

see_also📖NCT07477431 - Levetiracetam for Persons at Risk for Alzheime60%

see_also📖TRAILRUNNER-ALZ 1: Remternetug for Early Alzheimer's Di60%

mentions🧪APOE-TREM2 Interaction Modulation60%

mentions🧪TREM2-Mediated Selective Aggregate Clearance Pathway60%

mentions🧪TREM2-Dependent Microglial Senescence Transition60%

mentions🔬The disease-associated microglia (DAM) phenotype involves TR60%

mentions🔬Comprehensive analysis of immune cell subtypes in neurodegen60%

see_also📖Neurodegeneration60%

related🧪Complement C1q Mimetic Decoy Therapy58%

related🧪Complement C1q Subtype Switching58%

related🧪Complement-Mediated Synaptic Pruning Dysregulation58%

see_also📖BEACoN Study - Biomarker Exploration in Aging, Cognition and55%

see_also📖Antibody Therapy in Neurodegeneration55%

see_also📖Axon Guidance Pathways in Neurodegeneration55%

see_also📖Convergent Pathways in Neurodegeneration55%

see_also📖COVID-19 Neurodegeneration Mechanism55%

see_also📖Down Syndrome Neurodegeneration Pathway55%

see_also📖Dystrophic Neurites in Neurodegeneration55%

see_also📖Endosomal-Lysosomal Pathway in Neurodegeneration55%

see_also📖Galectin-3 Mechanism in Neurodegeneration55%

see_also📖gp130/IL-6 Family Cytokine Signaling in Neurodegeneration55%

see_also📖HMGB1 Signaling in Neurodegeneration55%

see_also📖IL-1 Signaling Pathway in Neurodegeneration55%

see_also📖Lipid Metabolism Dysregulation in Neurodegeneration55%

see_also📖Microglial Priming Pathway in Neurodegeneration55%

see_also📖Retinal Degeneration Pathway in Neurodegeneration55%

see_also📖Senescent Cell Clearance in Neurodegeneration55%

see_also📖Sex Differences in Neurodegeneration55%

see_also📖Therapeutic Targets in Neurodegeneration55%

see_also📖Transdiagnostic Proteomic Changes in Neurodegeneration55%

related🧪APOE-TREM2 Interaction Modulation54%

related🧪TREM2-Mediated Selective Aggregate Clearance Pathway54%

related🧪TREM2-Dependent Microglial Senescence Transition54%

related🔬The disease-associated microglia (DAM) phenotype involves TR54%

related🔬Comprehensive analysis of immune cell subtypes in neurodegen54%

mentions🧪Metabolic Reprogramming via Microglial Glycolysis Inhibition50%

mentions🧪Fractalkine Axis Amplification via CX3CR1 Positive Allosteri50%

mentions🧪Gamma entrainment therapy to restore hippocampal-cortical sy50%

mentions🧪Purinergic P2Y12 Inverse Agonist Therapy50%

mentions🧪Microbiome-Derived Tryptophan Metabolite Neuroprotection50%

mentions🧪Complement C1QA Spatial Gradient in Cortical Layers50%

mentions🧪APOE Isoform Expression Across Glial Subtypes50%

mentions🧪Interfacial Lipid Mimetics to Disrupt Domain Interaction50%

mentions🧪Targeted APOE4-to-APOE3 Base Editing Therapy50%

mentions🧪APOE4-Selective Lipid Nanoemulsion Therapy50%

mentions🧪Competitive APOE4 Domain Stabilization Peptides50%

mentions🧪Optogenetic Microglial Deactivation via Engineered Inhibitor50%

mentions🧪Microglial Purinergic Reprogramming50%

mentions🧪Heat Shock Protein 70 Disaggregase Amplification50%

mentions🧪Serine/Arginine-Rich Protein Kinase Modulation50%

mentions🧪Circadian Glymphatic Entrainment via Targeted Orexin Recepto50%

mentions🧪Magnetosonic-Triggered Transferrin Receptor Clustering50%

mentions🧪Designer TRAK1-KIF5 fusion proteins accelerate therapeutic m50%

related🔬What are the mechanisms underlying tdp-43 phase separation t50%

related🔬What are the mechanisms underlying blood-brain barrier trans50%

related🔬What are the mechanisms underlying synaptic pruning by micro50%

related🔬What are the mechanisms underlying mitochondrial transfer be50%

related🔬What are the mechanisms underlying perivascular spaces and g50%

related🔬Investigate prion-like spreading of tau pathology through co50%

related🔬SEA-AD Gene Expression Profiling — Allen Brain Cell Atlas50%

related🔬What are the mechanisms underlying tdp-43 phase separation t50%

related🔬What are the mechanisms underlying blood-brain barrier trans50%

related🔬What are the mechanisms underlying protein aggregation cross50%

related🔬What are the mechanisms underlying rna binding protein dysre50%

related🔬What are the mechanisms underlying synaptic pruning by micro50%

related🔬What are the mechanisms underlying mitochondrial transfer be50%

related🔬What are the mechanisms underlying perivascular spaces and g50%

related🔬Analyze circuit-level changes in neurodegeneration using All50%

related🔬Investigate prion-like spreading of tau pathology through co50%

related🔬SEA-AD Gene Expression Profiling — Allen Brain Cell Atlas50%

related🔬What are the most promising therapeutic strategies for targe50%

related🔬Anti-amyloid antibodies (lecanemab, donanemab) have ~0.1% br50%

related🔬RNA binding protein dysregulation across ALS FTD and AD50%

related🧪Selective APOE4 Degradation via Proteolysis Targeting Chimer50%

related🧪APOE Isoform Conversion Therapy50%

related🧪APOE4 Allosteric Rescue via Small Molecule Chaperones50%

related🧪APOE-Dependent Autophagy Restoration50%

related🧪Membrane Cholesterol Gradient Modulators50%

related🔬What are the mechanisms underlying 4r-tau strain-specific sp50%

see_also📖Cell-Free DNA Biomarkers in Neurodegeneration50%

see_also📖Exosomal Biomarkers in Neurodegeneration50%

see_also📖Exosomal miR-155 in Neurodegeneration50%

see_also📖IL-6 (Interleukin-6) in Neurodegeneration50%

see_also📖Liquid Biopsy in Neurodegeneration50%

see_also📖Metabolomic Biomarkers in Neurodegeneration50%

see_also📖Neuroimaging Biomarkers for Neurodegeneration50%

see_also📖sTREM2 (Soluble TREM2) - Microglial Biomarker50%

see_also📖sTREM2 (Soluble TREM2) - Biomarker50%

see_also📖Synaptic Biomarkers in Neurodegeneration50%

see_also📖Cannabidiol for Alzheimer's Disease Prevention (NCT058250%

see_also📖CORT108297 Phase 2 (NCT04601038) - Stress Attenuation in AD50%

see_also📖DBS Nucleus Basalis Trial (NCT07218081): Deep Brain Stimulat50%

see_also📖Donanemab TRAILBLAZER-ALZ 2 Trial50%

see_also📖EI-1071 Immunomodulator for Alzheimer's Disease (NCT06750%

see_also📖MK-1167 Phase 2 AD Trial (MK-1167-008)50%

see_also📖LX1001 Phase 1/2 Trial (NCT03634007) - Gene Therapy for APOE50%

see_also📖A Placebo-Controlled, Double-Blind, Parallel-Group, 18-Month50%

see_also📖A Phase IIB, Randomized, Double-Blind, Placebo-Controlled, M50%

see_also📖LX1001 Long-Term Follow-up (NCT05400330) - Gene Therapy for 50%

see_also📖nct0550878950%

see_also📖A Phase 2 Double-Blind, Randomized, Placebo-Controlled Trial50%

see_also📖ALA-enriched Nutrition for APOE4 Carriers with MCI (NCT0739250%

see_also📖Olfactory Mucosa, Blood and Urine for Identification of Earl50%

see_also📖remternetug-anti-amyloid-alzheimers50%

see_also📖Swedish BioFINDER 2 Study: Biomarkers and Neurodegeneration 50%

see_also📖Trontinemab (RO7126209) Phase 3 Trial — TRONTIER 2 (NCT0717050%

see_also📖UB-311 Alzheimer's Vaccination Trial50%

see_also📖UPenn Observational Research Repository (NCT04715399)50%

see_also📖APOE2 (Apolipoprotein E2)50%

see_also📖APOE3 (Apolipoprotein E3)50%

see_also📖APOE4 (Apolipoprotein E4)50%

see_also📖Beta-Propeller Protein-Associated Neurodegeneration (BPAN)50%

see_also📖China Neurodegeneration Epidemiology50%

see_also📖DALY Methodology — Neurodegeneration50%

see_also📖Disease Progression & Staging in Neurodegeneration50%

see_also📖Economic Burden — Neurodegeneration50%

see_also📖European Neurodegeneration Epidemiology50%

see_also📖Familial vs Sporadic Neurodegeneration Comparison50%

see_also📖Global Neurodegeneration Epidemiology50%

see_also📖India Neurodegeneration Epidemiology50%

see_also📖Japan Neurodegeneration Epidemiology50%

see_also📖Manganese-Related Neurodegeneration (Manganism)50%

see_also📖mitochondrial-dysfunction-neurodegeneration-comparison50%

see_also📖Mitochondrial Diseases and Neurodegeneration Comparison Matr50%

see_also📖Mitochondrial Membrane Protein-Associated Neurodegeneration 50%

see_also📖Neurodegeneration with Brain Iron Accumulation (NBIA)50%

see_also📖Potential Impact Measures — Neurodegeneration50%

see_also📖Pantothenate Kinase-Associated Neurodegeneration (PKAN)50%

see_also📖PLA2G6-Associated Neurodegeneration (PLAN)50%

see_also📖Sleep Disorders in Neurodegeneration50%

see_also📖US Neurodegeneration Epidemiology50%

see_also📖TREM2 Gene50%

see_also📖Extracellular Vesicle and Tunneling Nanotube-Mediated Spread50%

see_also📖acetylcholine-signaling-neurodegeneration50%

see_also📖Advanced Glycation End Products in Neurodegeneration50%

see_also📖Advanced In Vitro Models for Neurodegeneration — Organoids, 50%

see_also📖Amylin Signaling in Neurodegeneration50%

see_also📖Antisense Oligonucleotide (ASO) Therapy in Neurodegeneration50%

see_also📖Autosis Pathway in Neurodegeneration50%

see_also📖Basal Ganglia Circuit Dysfunction in Neurodegeneration50%

see_also📖becn1-autophagy-initiation-neurodegeneration-causal-chain50%

see_also📖CaMKII Signaling Pathway in Neurodegeneration50%

see_also📖Carbonic Anhydrase Modulator Therapy in Neurodegeneration50%

see_also📖Cerebral Amyloid Angiopathy in Neurodegeneration50%

see_also📖Cerebral Amyloid Angiopathy Pathway in Neurodegeneration50%

see_also📖Cholinergic System Dysfunction in Neurodegeneration50%

see_also📖Chrononutrition and Time-Restricted Eating in Neurodegenerat50%

see_also📖Neural Circuits in Neurodegeneration50%

see_also📖Cognitive Reserve and Resilience in Neurodegeneration50%

see_also📖Computational Disease Models for Neurodegeneration50%

see_also📖Copper Homeostasis in Neurodegeneration50%

see_also📖Diffusion MRI (DTI) in Neurodegeneration50%

see_also📖Digital Phenotyping in Neurodegeneration50%

see_also📖Endocannabinoid System in Neurodegeneration50%

see_also📖Endosomal Sorting Defects in Neurodegeneration50%

see_also📖Endothelin Signaling Pathway in Neurodegeneration50%

see_also📖epigenetics-neurodegeneration50%

see_also📖ESCRT-III Inhibition by Alpha-Synuclein in Neurodegeneration50%

see_also📖FA2H-Associated Neurodegeneration Pathway50%

see_also📖Farnesoid X Receptor (FXR) Signaling in Neurodegeneration50%

see_also📖Gangliosides in Neurodegeneration50%

see_also📖GDF15/GDF11 Signaling in Neurodegeneration50%

see_also📖GDNF Signaling Pathway in Neurodegeneration50%

see_also📖Ghrelin Signaling Pathway in Neurodegeneration50%

see_also📖Glucocorticoid Signaling Pathway in Neurodegeneration50%

see_also📖Glycosylation in Neurodegeneration50%

see_also📖Hippocampal Neurogenesis in Neurodegeneration50%

see_also📖Histone Modification Pathways in Neurodegeneration50%

see_also📖Homocysteine Neurotoxicity and Neurodegeneration50%

see_also📖IGF-1 Signaling Pathway in Neurodegeneration50%

see_also📖Integrated Stress Response in Neurodegeneration50%

see_also📖interleukin-6-signaling-neurodegeneration50%

see_also📖Intrinsic Apoptosis Pathway in Neurodegeneration50%

see_also📖Ion Channel Dysfunction in Neurodegeneration: Cross-Disease 50%

see_also📖Kidney-Brain Neurodegeneration Axis50%

see_also📖Lipid Dysregulation in Neurodegeneration50%

see_also📖Lysosomal Calcium Dysregulation in Neurodegeneration50%

see_also📖Magnetic Resonance Spectroscopy in Neurodegeneration50%

see_also📖Metal Homeostasis Dysregulation in Neurodegeneration50%

see_also📖Metal Homeostasis in Neurodegeneration50%

see_also📖MicroRNA Dysfunction in Neurodegeneration50%

see_also📖Mineralocorticoid Receptor Signaling in Neurodegeneration50%

see_also📖Mitochondrial Dynamics Pathway in Neurodegeneration50%

see_also📖Mitochondrial Fusion in Neurodegeneration50%

see_also📖Molecular Chaperones in Neurodegeneration50%

see_also📖mTOR Signaling in Neurodegeneration50%

see_also📖mTOR Signaling Pathway in Neurodegeneration50%

see_also📖Neural Circuit Disruption in Neurodegeneration50%

see_also📖Neurexin/Neuroligin Synaptic Adhesion Modulator Therapy in N50%

see_also📖Neurofilament Light Chain (NfL) Mechanism in Neurodegenerati50%

see_also📖Neuronal Hyperexcitability in Neurodegeneration50%

see_also📖Neuropil Threads in Neurodegeneration50%

see_also📖Neurotensin Signaling in Neurodegeneration50%

see_also📖Neurovascular Unit Dysfunction in Neurodegeneration50%

see_also📖NF-kB Signaling Pathway in Neurodegeneration50%

see_also📖Nitric Oxide Signaling in Neurodegeneration50%

see_also📖Noradrenergic Signaling Pathway in Neurodegeneration50%

see_also📖Neuropeptide Y Signaling in Neurodegeneration50%

see_also📖NRF2 Signaling Pathway in Neurodegeneration50%

see_also📖Nuclear Pore Complex Dysfunction in Neurodegeneration50%

see_also📖Orexin Signaling in Neurodegeneration50%

see_also📖OSK Reprogramming and Yamanaka Factors in Neurodegeneration50%

see_also📖P-Body (Processing Body) Pathway in Neurodegeneration50%

see_also📖Paranodal Dysfunction in Neurodegeneration50%

see_also📖Paraptosis in Neurodegeneration50%

see_also📖Parthanatos in Neurodegeneration50%

see_also📖Pericyte Loss in Neurodegeneration50%

see_also📖Peripheral Immune-Brain Crosstalk in Neurodegeneration50%

see_also📖PKR Pathway in Neurodegeneration50%

see_also📖PPAR Signaling Pathway in Neurodegeneration50%

see_also📖Prion Diseases in Neurodegeneration50%

see_also📖Prion-Like Spread in Neurodegeneration50%

see_also📖Prion Protein Metabolism in Neurodegeneration50%

see_also📖Progesterone Signaling Pathway in Neurodegeneration50%

see_also📖Prognostic Biomarkers in Neurodegeneration50%

see_also📖Protein Aggregation Comparison in Neurodegeneration50%

see_also📖Protein Aggregation Seeds in Neurodegeneration50%

see_also📖Protein O-GlcNAcylation Pathway in Neurodegeneration50%

see_also📖Cortical Involvement and Neurodegeneration in Progressive Su50%

see_also📖Purinergic Signaling in Neurodegeneration50%

see_also📖Quantum Biology and Coherent Energy Transfer in Neurodegener50%

see_also📖R-Loop Stress in Neurodegeneration50%

see_also📖RAN Translation in Neurodegeneration50%

see_also📖Ribosome Dysfunction in Neurodegeneration50%

see_also📖RNA Splicing in Neurodegeneration50%

see_also📖RNA-Targeted Therapies in Neurodegeneration50%

see_also📖Ribonuclease κ and Circular RNAs: A New Mechanism of Aging a50%

see_also📖S100 Protein Signaling Pathway in Neurodegeneration50%

see_also📖Serotonergic Dysfunction in Neurodegeneration50%

see_also📖Short Chain Fatty Acids in Neurodegeneration50%

see_also📖Sigma-1 Receptor Signaling in Neurodegeneration50%

see_also📖Sirtuin-Mitochondrial Biogenesis Axis in Neurodegeneration50%

see_also📖Sleep Dysfunction in Neurodegeneration50%

see_also📖SUMOylation in Neurodegeneration50%

see_also📖synaptic-vesicle-cycling-neurodegeneration50%

see_also📖Synthetic Lethality and PARP Inhibition in Neurodegeneration50%

see_also📖T-Cell Dysfunction in Neurodegeneration50%

see_also📖Tertiary Lymphoid Organs in Neurodegeneration50%

see_also📖ubiquitin-proteasome-dysfunction-neurodegeneration50%

see_also📖Ubiquitin-Proteasome System Dysfunction in Neurodegeneration50%

see_also📖Vagus Nerve Pathway in Neurodegeneration50%

see_also📖VEGF Signaling and Cerebral Angiogenesis in Neurodegeneratio50%

see_also📖vip-vasoactive-intestinal-peptide-signaling-neurodegeneratio50%

see_also📖WNK1-Bilirubin Signaling in Neuroinflammation and Neurodegen50%

see_also📖WNK1 Kinase in Neurodegeneration50%

see_also📖Wnt/β-Catenin Signaling Pathway in Neurodegeneration50%

see_also📖ExPlas — Exercise Plasma Transfusion for Alzheimer's Di45%

see_also📖Latrepirdine (DMB-I) Phase 3 Trial for Alzheimer's Dise45%

see_also📖KarXT for Alzheimer's Disease Cognitive Impairment - MI45%

see_also📖A Phase 3, Randomised, Double-blinded, Placebo-controlled St45%

see_also📖Novartis Alzheimer's Disease Phase 2 Trial (NCT0709451645%

see_also📖Master Screening Study to Determine Individuals With Potenti45%

see_also📖X/T + X-EC + Lecanemab Phase 2 (NCT07212062) — Alzheimer45%

see_also📖Exciva Alzheimer's Disease Phase 2/3 Trial45%

see_also📖Rotigotine and Rivastigmine Combination Therapy for Alzheime45%

see_also📖TRAP-AD: Transcranial Photobiomodulation for Alzheimer'45%

see_also📖VY7523 Phase 1/2 Alzheimer's Disease Trial45%

see_also📖APOE4 and Alzheimer's Disease Risk45%

see_also📖TREM2 in Amyotrophic Lateral Sclerosis45%

see_also📖TREM2 in Frontotemporal Dementia45%

see_also📖TREM2 Gene-Mechanism-Therapy Chain — From Genetic Risk to Th45%

mentions🔬What are the most promising therapeutic strategies for targe40%

mentions🔬What are the mechanisms underlying protein aggregation cross40%

mentions🔬What are the mechanisms underlying rna binding protein dysre40%

mentions🔬RNA binding protein dysregulation across ALS FTD and AD40%

mentions🔬Analyze circuit-level changes in neurodegeneration using All40%

mentions🔬Anti-amyloid antibodies (lecanemab, donanemab) have ~0.1% br40%

related🧪Designer TRAK1-KIF5 fusion proteins accelerate therapeutic m40%

related🧪Heat Shock Protein 70 Disaggregase Amplification40%

related🧪Circadian Glymphatic Entrainment via Targeted Orexin Recepto40%

related🧪Magnetosonic-Triggered Transferrin Receptor Clustering40%

related🧪Serine/Arginine-Rich Protein Kinase Modulation40%

related🧪TREM2 Conformational Stabilizers for Synaptic Discrimination35%

related🧪Cell-Type Specific TREM2 Upregulation in DAM Microglia35%